Pre-Heparin Plasma Lipoprotein Lipase Mass: Correlation With Intra-Abdominal Visceral Fat Accumulation

Objective: To determine how lipoprotein lipase mass in the pre-heparin plasma is affected by body fat distribution, which is known to be closely related to lipid disorder, either directly or through insulin resistance. Subjects: A total of 57 subjects consisting of 50 hyperlipidemic and 7 normolipidemic subjects (age 54 ± lly; 31 men, 26 women; body mass index 24 ± 2.5 kg/m²; serum total cholesterol 6.4 ± 1.5 mmol/l; triglycerides, 2.4 ± 1.7 mmol/l; HDL-cholesterol 1.3 ± 0.5 mmol/l) were enrolled. Measurements: We investigated the correlation between pre-heparin plasma LPL mass and intra-abdominal visceral fat area (or subcutaneous fat area) evaluated by computed tomography, and serum lipids and lipoproteins. Results: Pre-heparin plasma LPL mass correlated inversely against intra-abdominal visceral fat area (r = - 0.51, p < 0.0001) and body mass index (r = - 0.46, p = 0.0003), but did not show any significant correlation with subcutaneous fat area. Pre-heparin plasma LPL mass had a positive correlation with serum high density lipoprotein cholesterol (r = 0.45, p = 0.0004) and a negative correlation against serum triglycerides (r = - 0.48, p = 0.0002). Conclusions: Pre-heparin plasma LPL mass is closely associated with intra-abdominal fat distribution, and the measurement of its value gives useful information concerning metabolic disorder.

Hyperlipidemia - Insulin - Triglycerides - Body Mass Index - Subcutaneous Fat

References

• 1 Havel R J, Kane J P, Kashyap M L. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.  J Clin Invest. 1973;  52 32-38
• 2 Nilsson-Ehle P, Garfinkel A S, Schotz M C. Lipolytic enzymes and plasma lipoprotein metabolism.  Ann Rev Biochem. 1980;  49 667-693
• 3 Brunzell J D. The metabolic and molecular basis of inherited disease.  New York:; Me Graw-Hill Inc., 1995: 1913-1932
• 4 Vilella E, Joven J, Fernandez M, Vilaro S, Brunzell J D, Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.  J Lipid Res. 1993;  34 1555-1564
• 5 Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin injection.  Arterioscler Thromb Vase Biol. 1995;  15 1086-1093
• 6 Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K. Preheparin serum lipoprotein lipase mass level: the effects of age, gender and type of hyperlipidemia.  Atherosclerosis,. 1999;  145 45-50
• 7 Williams K J, Fless G M, Petrie K A, Snyder M L, Brocia R W, Swenson T L. Mechanism by which lipoprotein lipase alters cellular metabolism of lipoprotein (a), low density lipoprotein, and nascent lipoproteins: roles for low density lipoprotein receptors and heparan sulphate proteoglycans.  J Biol Chem. 1992;  267 13 284-13 292
• 8 Vague J. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease.  Am J Clin Nutr. 1956;  4 20-34
• 9 Kissebah A H, Vydelingum N, Murray R, Evans D J, Hartz A J, Kalkhoff R K, Adams P W. Relation of body fat distribution to metabolic complication of obesity.  J Clin Endocrinol Met. 1982;  54 254-260
• 10 Herranz L, Zapata A, Grande C, Megio A, Pallardo L F. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.  Horm Metab Res. 1998;  30 141-145
• 11 Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography.  International Journal of Obesity. 1983;  7 437-445
• 12 Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Depres J P. Post-prandial triglyceride response in visceral obesity in men.  Diabetes. 1998;  47 953-960
• 13 Kobayashi J, Tashiro J, Murano S, Morisaki N, Saito Y. Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation.  Clin Endocrinology. 1998;  48 515-520
• 14 Taira K, Hikita M, Kobayashi J, Bujo H, Takahashi K, Murano S, Morisaki N, Saito Y. Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation.  Eur J Clin Invest. 1999;  29 301-308
• 15 Nakamura M, Taniguchi Y, Yamamoto M, Hino K, Manabe M. Homogenous assay of serum LDL-cholesterol on an automatic analyzer.  Clin Chem. 1997;  43 S260-S261
• 16 Murai T, Nasu Y. Evaluation of a new homogeneous assay kit for serum HDL cholesterol determinations.  Clin Chem. 1997;  43 S260
• 17 Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam W, Keno Y, Kobatake T, Nagai Y, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men.  Atherosclerosis. 1994;  107 239-246
• 18 Walton C, Lees B, Crook D, Worthington M, Godsland I F, Stevenson J C. Body fat distribution, rather then overall adiposity, influence serum lipids and lipoproteins in healthy men independently of age.  American J Med. 1995;  99 459-464
• 19 Rimm E B, Stampfer M J, Giovannucci E, Ascherio A, Spiegelman D, Colditz G A, Willett W C. Body size and fat distribution as predictors of coronary heart disease among middle aged and older US men.  American J Epidemi. 1995;  141 1117-1127
• 20 Bjorntop P. Abdominal obesity and the development of NIDDM.  Diabetes Metab Rev. 1988;  4 615-619